Xponance, Inc. Guardant Health, Inc. Transaction History

Xponance, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $120,187 - $238,131	7,479 New	7,479 $215,000
Q2 2023 Jul 13, 2023	SELL	$20.94 - $38.01 $145,595 - $264,283	-6,953 Reduced 51.51%	6,545 $234,000
Q1 2023 Apr 17, 2023	BUY	$22.92 - $33.76 $10,566 - $15,563	461 Added 3.54%	13,498 $316,000
Q4 2022 Jan 23, 2023	BUY	$25.44 - $59.78 $35,565 - $83,572	1,398 Added 12.01%	13,037 $0
Q3 2022 Oct 24, 2022	BUY	$43.66 - $61.0 $11,744 - $16,409	269 Added 2.37%	11,639 $627,000
Q2 2022 Aug 02, 2022	BUY	$28.82 - $77.35 $30,289 - $81,294	1,051 Added 10.19%	11,370 $459,000
Q1 2022 Apr 20, 2022	BUY	$48.25 - $100.49 $9,167 - $19,093	190 Added 1.88%	10,319 $684,000
Q4 2021 Jan 31, 2022	BUY	$88.71 - $120.43 $266 - $361	3 Added 0.03%	10,129 $1.01 Million
Q3 2021 Nov 05, 2021	SELL	$98.77 - $132.17 $19,260 - $25,773	-195 Reduced 1.89%	10,126 $1.27 Million
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $201,647 - $304,354	1,837 Added 21.65%	10,321 $1.28 Million
Q1 2021 May 10, 2021	SELL	$127.04 - $179.1 $5,462 - $7,701	-43 Reduced 0.5%	8,484 $1.3 Million
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $79,168 - $107,656	792 Added 10.24%	8,527 $1.1 Million
Q3 2020 Oct 26, 2020	SELL	$80.32 - $111.8 $2,570 - $3,577	-32 Reduced 0.41%	7,735 $865,000
Q2 2020 Aug 14, 2020	BUY	$60.49 - $97.5 $469,825 - $757,282	7,767 New	7,767 $630,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.